SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  SUN-RANBAXY DEAL AN ACID TEST FOR COMPETITION REGULATOR

[August 11, 2014]

SUN-RANBAXY DEAL AN ACID TEST FOR COMPETITION REGULATOR

(Indian Business Insight Via Acquire Media NewsEdge) The $3.2 billion acquisition of Ranbaxy Laboratories Ltd (RLL) by Sun Pharmaceutical Industries will be a test for the industry friendliness of the Competition Commission of India (CCI). The CCI has so far cleared most merger and acquisition (M&A) applications that have come before it. The Sun-Ranbaxy transaction is the first merger deal that has received a show- cause notice from CCI, since the Government of India amended the merger control provision in 2011. The acquisition of RLL by Sun has given Sun a dominant position in the Indian drug market. The CCI may ask Sun's competitors if they have any objection to the deal.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy